Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novo-Helisen Depot in House Dust Mite Allergy
NCT00263549Phase 4Completed
- Sponsor
- Allergopharma
- Start
- Sep 2002
- Primary completion
- Feb 2005
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic rhinoconjunctivitis (ARC) comparing Novo-Helisen Depot with Placebo (2 arms). Primary endpoint: Allergen threshold for positive Nasal Provocation Test result. Started Sep 2002; status: completed.
02
Drugs
Novo-Helisen Depot
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00263549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263549.